Biologics is an international, multidisciplinary, peer-reviewed, and scientific open access, open source journal that encourages authors to submit high-quality original research papers, reviews, and communications in all areas of biologics derived from both novel and established biotechnologies. Biologics is published quarterly online by MDPI.
  • Open Access—free to download, share, and reuse content. Authors receive recognition for their contribution when the paper is reused.
  • Rapid Publication: manuscripts are peer-reviewed and a first decision provided to authors approximately 15.4 days after submission; acceptance to publication is undertaken in 2.5 days (median values for papers published in this journal in the first half of 2021).
  • Recognition of Reviewers: APC discount vouchers, optional signed peer review, and reviewer names published annually in the journal.
  • Biologics is a companion journal of JCM.
Add your e-mail address to receive forthcoming issues of this journal:
Special Issue in Biologics
Recent Advances in the Development of Veterinary Biologics Guest Editors: Alexander Zakhartchouk, Francois Meurens, Anastasia N. Vlasova
Deadline: 31 December 2021
Special Issue in Biologics
Antiviral Peptides - From Discovery to Translation Guest Editor: Kai Hilpert
Deadline: 30 June 2022
Special Issue in Biologics
Public Health Emergencies and Threats: From Vaccine Efficacy to Antimicrobial Resistance Guest Editors: Marco Montalti, Davide Gori
Deadline: 31 July 2022
Special Issue in Biologics
Biological Therapies for Neurodegenerative Diseases Guest Editor: Damian Holsinger
Deadline: 31 August 2022
Back to TopTop